Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Berthou

Showing results (21-30 of 187) with videos related to

Pageof 19
Sort By:
Critical Reviews in Oncology/Hematology|January 2, 2007
Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatmentSeverine Loisel, Marc Ohresser, Marc Pallardy, et al.
Immunology|July 5, 2007
Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosusSophie Hillion, Soizic Garaud, Valérie Devauchelle, et al.
Oncotargets and Therapy|October 23, 2015
ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four casesRodica Ungur, Adrian Tempescul, Christian Berthou, et al.
Annals of the New York Academy of Sciences|September 18, 2009
Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1Amani Mankaï, Virginie Buhé, Mariam Hammadi, et al.
Annals of Hematology|January 14, 2009
Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphomaAdrian Tempescul, Jean-Christophe Ianotto, Frederic Morel, et al.
Clinical Reviews in Allergy & Immunology|May 31, 2019
Complement System: a Neglected Pathway in ImmunotherapyAnne Bordron, Cristina Bagacean, Adrian Tempescul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytesSoizic Garaud, Christelle Le Dantec, Christian Berthou, et al.
Haematologica|September 12, 2006
Beta-thalassemia in the indigenous population of Brittany: identification of three rare mutationsDéborah Jamet, Serge Pissard, Marie-Thérèse Blouch, et al.
Journal De La Societe De Biologie|December 25, 2007
[Initiation factors eIF4: from sea urchin embryonic development to chronic lymphocytic leukemia]Hussam Saad, Robert Bellé, Julia Morales, et al.
Critical Reviews in Clinical Laboratory Sciences|April 3, 2019
Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectivesCristina Bagacean, Ciprian Tomuleasa, Adrian Tempescul, et al.
Pageof 19

Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Critical Reviews in Oncology/Hematology|January 2, 2007
Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatmentSeverine Loisel, Marc Ohresser, Marc Pallardy, et al.
Immunology|July 5, 2007
Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosusSophie Hillion, Soizic Garaud, Valérie Devauchelle, et al.
Oncotargets and Therapy|October 23, 2015
ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four casesRodica Ungur, Adrian Tempescul, Christian Berthou, et al.
Annals of the New York Academy of Sciences|September 18, 2009
Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1Amani Mankaï, Virginie Buhé, Mariam Hammadi, et al.
Annals of Hematology|January 14, 2009
Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphomaAdrian Tempescul, Jean-Christophe Ianotto, Frederic Morel, et al.
Clinical Reviews in Allergy & Immunology|May 31, 2019
Complement System: a Neglected Pathway in ImmunotherapyAnne Bordron, Cristina Bagacean, Adrian Tempescul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytesSoizic Garaud, Christelle Le Dantec, Christian Berthou, et al.
Haematologica|September 12, 2006
Beta-thalassemia in the indigenous population of Brittany: identification of three rare mutationsDéborah Jamet, Serge Pissard, Marie-Thérèse Blouch, et al.
Journal De La Societe De Biologie|December 25, 2007
[Initiation factors eIF4: from sea urchin embryonic development to chronic lymphocytic leukemia]Hussam Saad, Robert Bellé, Julia Morales, et al.
Critical Reviews in Clinical Laboratory Sciences|April 3, 2019
Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectivesCristina Bagacean, Ciprian Tomuleasa, Adrian Tempescul, et al.
Pageof 19